Videos de Experimentos Relacionados
¿Cuál de las funciones normales de la tiroides es mejor, la tuya o la mía?
Colin M Dayan1, Ponnusamy Saravanan, Graham Bayly
1University Research Centre for Neuroendocrinology, Bristol Royal Infirmary, Bristol BS2 8HW, UK. colin.dayan@bris.ac.uk
Lancet (London, England)
|September 21, 2002
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Overlap of Gestational Diabetes Mellitus and Pre-eclampsia: A Scoping Review.
Diabetes therapy : research, treatment and education of diabetes and related disorders·2026
Same author
Hypertension: A common, yet poorly managed condition. What can we do better?
Clinical medicine (London, England)·2026
Same author
Prediabetes before pregnancy: implications for risk stratification and research.
Current opinion in endocrinology, diabetes, and obesity·2026
Same author
Serial Dried Blood Spot C-Peptide Sampling, but Not Urine C-Peptide-to-Creatinine Ratio, Detects Early Preservation of β-Cell Function in New-Onset Type 1 Diabetes: Experience From the USTEKID Trial.
Diabetes care·2026
Same author
Relevance of Quantitative Measures of Beta-Cell Function in Clinical Practice.
Hormone research in paediatrics·2026
Same author
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.
Cardiovascular diabetology·2026
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026